Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Studying > CPS Neonatology > Flashcards

CPS Neonatology Flashcards

1
Q

Natural history of perinatal brachial plexus palsy injury

A
  • ~25% have residual defects
  • 75% recover completely within 1st month
  • If physical exam shows incomplete recovery by 3-4 weeks then full recovery is unlikely
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

CPS does not recommend infant car seat challenge for these 4 reasons:

A
  • Inconsistency among ICSC tests
  • Lack of evidence that failing is associated with adverse outcomes
  • Poor reproducibility
  • Not as accurate as PSG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When and to whom to do CCHD screening

A
  • All term and late prems
  • Asymptomatic in nonacute settings
  • Between 24 and 36 hrs of age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What to do with a failed CCHD screen

A
  • Asses by MRP
  • May do: 4 limb BPs, ECG, CXR
  • Consult pediatrician
  • If stll unclear  echo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

< 23 weeks survival to discharge

A

20
(30% severe NDD)
- Palliative care is recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

23-23+6

  • survival (%)
  • recommendations on resuscitation
A

40
(20% severe NDD)
- Intensive care or palliative care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

24-24+6

  • survival (%)
  • recommendations on resusucitation
A

67%
(20% severe NDD)
- Intensive care or palliative care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

> 25 weeks

  • survival rates (%)
  • recommendation on resuscitation
A

80
(14% severe NDD)
- Intensive care is recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prognostic factors for extreme prems

besides GA

A
  • Birth weight
  • Singleton vs. multiple
  • Antenatal corticosteroids
  • Gender (males to do worse)
  • Birth outside a tertiary perinatal centre
  • Chorioamnionitis
  • Major congenital anomalies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Potential risk of circumcision

A
  • Minor bleeding
  • Local infection
  • Severe infection
  • Death
  • Unsatisfactory cosmetic results
  • Meatal stenosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Potential benefits of circumcision

A
  • Prevention of phimosis
  • Decrease in early UTI
  • Decrease in UTI in males with risk factors
  • Decreased acquisition of HIV
  • Decreased acquisition of HPV
  • Decreased penile cancer risk
  • Decreased cervical cancer risk in female partners
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Contraindications to neonatal circumcision

A
  • Hypospadias

- Bleeding diathesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Post-discharge problems of late preterm

A
  1. Hyperbilirubinemia
  2. Feeding difficulties and growth
  3. Apnea and SIDS
  4. Sepsis
  5. Hypoglycemia and temperature control
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

4 important infant competencies of premature infant

A
  1. Thermoregulation
  2. Control of breathing
  3. Respiratory stability
  4. Feeding skills and weight gain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

If NBS is done before 24hrs must have a repeat done within…

A

7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

TSB or TCB should be measuring in all infants during…

A

First 72hr of life

- If not required earlier due to clinical jaundice, should do as same time as NBS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Acute bilirubin encephalopathy

A

Clinical syndrome in presence of severe hyperbili:
Lethargy, hypotonia and poor suck may progress to hypertonia (oisthotonos and retrocollis) with high-pitched cry and fever and eventually to seizures and coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Features of chronic bilirubin encephalopathy

A

Athetoid CP

+/- seizures, dev delay, hearing deficit, oculomotor disturbances, dental dysplasia, mental deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Severe hyperbilirubinemia

A

> 340 umol/L (at any time during first 28 days)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Critical hyperbilirubinemia

A

TSB >425umol/L during first 29 days of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cons of transcutaneous bili

A
  • Unreliable after initiation of phototherapy
  • Unreliable with changes in skin colour and thickness
    (more accurate at lower levels so better as a screening devise)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Side effects of phototherapy

A
  • Temperature instability
  • Water loss
  • Intestinal hypermotility
  • Diarrhea
  • Interference with maternal-infant interaction
  • Rarely: bronze discoloration of the skin
  • Potential risk (animal studies) or retinal damage
  • Parental anxiety and health care use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Side effects of phototherapy

A
  • Temperature instability
  • Water loss
  • Intestinal hypermotility
  • Diarrhea
  • Interference with maternal-infant interaction
  • Rarely: bronze discoloration of the skin
  • Potential risk (animal studies) or retinal damage
  • Parental anxiety and health care use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Before exchange transfusion collect blood for investigation of rare causes:

A
  • Red cell fragility
  • Enzyme deficiency – G6PD and PK
  • Metabolic disorder
  • Hemoglobin electrophoresis
  • Chromosome analysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Benefits of therapeutic hypothermia

A
  • Decrease mortality
  • Decrease mod-to-severe neurodevelopmental delay
  • Increase survival without neurodev delay
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Treatment criteria for therapeutic cooling

Inclusion criteria

A
  1. > = 36 weeks GA
  2. < = 6hrs of age
  3. Either criteria A+C OR criteria B+C
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Criteria A, B and C in therapeutic hypothermia

A 
A = cord pH < 7.0, base deficits >= -16
B = pH 7.01-7.15 or base deficit -10 to -15.9 on cord gas or gas < 1hr AND hx of acute perinatal event AND Apgar < 5 at 10 minutes or at least 10 minutes of PPV
C = evidence of mod-to-severe encephalopathy aka seizures or signs in 3+ of 6 categories of Sarnat staging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

6 categories of Sarnat staging

A
  1. Level of consciousness
  2. Spontaneous activity
  3. Posture
  4. Tone
  5. Primitive reflexes
  6. Autonomic system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Contraindications for therapeutic hypothermia

A
  • Moribund infants
  • Major congenital or genetic abnormalities
  • Severe IUGR
  • Clinically significant coagulopathy
  • Severe head trauma or intracranial bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Side effects of hypothermia

6

A
  • Sinus brady
  • Hypotension
  • Thrombocytopenia
  • Prolonged bleeding time
  • Subcutaneous fat necrosis
  • Persistent pulmonary hypertension with impaired oxygenation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Target temperature to be reached with hypothermia

A

Optimal rectal/esophageal: 33.5+/- 0.5C for whole body cooling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Sarnat stages pupils

A

Stage 1: mydriasis
Stage 2: miosis
Stage 3: unequal, poor light reflex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Infants at risk for hypoglycemia

A
  • Weight < 10th percentile
  • IUGR
  • Weight > 90th percentile
  • Infants of diabetic mothers
  • Prem < 37 weeks GA
  • Maternal labetalol use
  • Late prem exposure to antenatal steroids
  • Perinatal asphyxia
  • Metabolic: e.g. CPT-1 deficiency
  • Certain syndromes e.g. Beckwith-Wiedemann
34
Q

Duration of hypoglycemia screening

A

IDM and LGA – 12hrs

SGA and prems – 24 hrs

35
Q

When to send critical sample

A

> 72 hrs: at BG <= 2.8

36
Q

Critical sample

10 investigations

A
  • Plasma glucose
  • Beta-hydroxybutyrate
  • Bicarbonate
  • Lactate
  • Free fatty acids
  • Insulin
  • Growth hormone
  • Cortisol
  • Carnitine
  • Acylcarnitine profiling
37
Q

Hypoglycemia at 2 hrs of life

- If < 2.6

A
  • 40% dextrose gel 0.5mL/kg and breast feed OR
  • 5mL/kg and breastfeed
    Check glucose 30 min post feed
38
Q

Hypoglycemia after first 2 hrs

- If <= 1.8

A
  • D10W infusion
  • If symptomatic: D10W bolus 2mL/kg over 15 minutes
    Check glucose after 30 min
39
Q

Hypoglycemia after first 2 hrs

- 1.8-2.6

A
  • 40% dextrose gel 0.5mL/kg AND feed 5mL/kg and breastfeed OR
  • Feed 8mL/kg and breastfeed
    Check glucose 30 min post feed
40
Q

Who should be treated with iNO?

A
  • Infants >= 35 weeks at birth with hypoxemic resp failure who fail to respond to other measures
  • Infants with OI > 20-25 when PaO2 remains < 100 despite optimal ventilation with 100% FiO2
  • Ideally after an echo
41
Q

When and how to wean iNO

A
  • After 4-6hrs of stability where FiO2 is <60-80 or OI <=10
  • Wean by 50% q4-6hr intervals if OI remains <= 10
  • At 5ppm then wean by 1ppm q 4 hrs and then discontinued at 1ppm
42
Q

Benefit of iNO

A

Improves oxygenation

Decreases combined outcome of death or ECMO (mostly by decreasing need for ECMO)

43
Q

Physiologic responses to intubation

A
  • Systemic and pulmonary hypertension (can be reduced with analgesia)
  • Bradycardia (can be prevented with atropine)
  • Intracranial hypertension (can be avoided with muscle relaxants)
  • Hypoxia (reduced with paralysis)
44
Q

Suggested protocol for admin of premedication for intubation for neonates

A
  1. Atropine 20ug/kg IV
  2. Fentanyl 3-5ug/kg IV (slow infusion)
  3. Succinylcholine 2mg/kg IV
    * fentanyl at risk for frozen chest!
45
Q

Benefits of kangaroo care

  • for the prem infant (6)
  • for the mom (3)
A

For baby:

  • cardioresp and temp stability
  • decreased arousal and decreased REM (more mature sleep)
  • increased sleep time
  • increased neurodevelopmental outcomes after discharge
  • decreased nosocomial infection
  • reduced responses to pain

For mom/parent:

  • longer duration of breastfeeding
  • higher volumes of milk
  • increased maternal confidence
46
Q

Hemoglobin thresholds in prem infants with resp supports

A

Week 1: 115
Week 2: 100
Week 3: 85

47
Q

Hemoglobin thresholds in prem infants without resp supports

A

Week 1: 100
Week 2: 85
Week 3: 75

48
Q

“Respiratory support” in premature infant transfusion guidelines

A
  • FIO2 of 25%+

- mechanical increase in airway pressure

49
Q

Opioid use during pregnancy can be associated with

A
  • Prematurity
  • Low birth weight
  • Increased risk of spontaneous abortion
  • SIDS
  • Infant neurobehavioural abnormalities
  • Neonatal abstinence
50
Q

Neonatal abstinence syndrome how long to screen for

A
  • Minimum of 72 hr

- Up to 120 hrs when infant has a longer-acting opioid e.g. methadone or buprenorphine

51
Q

Naloxone during infant resuscitation is associated with

A

Seizures

52
Q

2 patterns of brain injury in HIE and significance

A
  1. Watershed (prolonged partial hypoxia-ischemia) – more cognitive impairment than motor
  2. Basal ganglia/thalamic (acute, profound hypoxia-ischemia) – severe motor and cognitive
53
Q

Timing for MRI in term neonate with neonatal encephalopathy

A
  1. Between 3 and 5 days of life then

2. Repeat MRI at 10-14 days = helpful adjunct

54
Q

Pros and cons for ultrasound in term neonate brain imaging

A
  • Can help identify hemorrhage, major structural anomalies or calcifications
  • NOT recommended as sole imaging modality in term neonates
55
Q

CT may be useful first imaging modality when

A
  • Urgent situations
  • MRI is not available
  • Infant is too unstable to undergo MRI
  • Trauma or skull fracture is suspected
56
Q

Grading for IVH

A
  1. Limited to germinal matrix
  2. IVH involves blood in ventricles
  3. IVH has blood filling and distending ventricular system
  4. Parenchymal involvement
57
Q

Grading for PVL on head ultrasound

A
  1. Transient periventricular areas with increased echogenicity for 7 days or more
  2. Small, localized, fronto-parietal cysts
  3. Extensive periventricular cystic lesions
  4. Increased echogenicity in deep white matter which are evolving into extensive cystic lesions
58
Q

Neuroimaging timing for premature infants

A

<= 31+6 weeks:
Scheduled: HUS @ 7-14 days post-birth and HUS at 4-6 weeks post-birth
- Term corrected imaging if markedly abN findings or RFs (not routine)
- f/u HUSs 7-10 days after initial if grade 2 or higher IVH or WMI or complication

32+ weeks: do initial HUS if RFs, follow up imaging only if abnormal

59
Q

Risk factors for IVH

A 
Prematurity (#1)
Low birth weight < 1000g
Chorioamnionitis
Events leading to cerebral blood flow instability
Lack of antenatal corticosteroids
Birth outside of a tertiary care centre
60
Q

Risk factors for abnormal brain imaging in prems > 32 weeks

A
  • Lower GA
  • HC <3rd percentile
  • Resuscitation at birth or critical care out of keeping of usual neonatal course
  • Complicated monochorionic twin pregnancy
  • Postnatal complications
61
Q

Mothers with PPROM and infant <=32+6:

A
  • Should be treated with penicillin and a macrolide

neuroprotection

62
Q

Gestation age for antenatal steroids

neuroprotection

A

<34+6 (select cases 35-36+6)

Optimal interval >48hrs between last dose and birth

63
Q

Indications for Magnesium sulfate for mothers (neuroprotection)

A
  • Imminent preterm delivery (<=33+6)
64
Q

Neuroprotection measures for a prem infant (12)

  • before delivery (4)
  • at delivery (2)
  • after delivery for baby
A 
Before delivery:
1. Treat moms with PPROM
2. Transfer moms to tertiary care centre
3. antenatal corticosteroids
4. magnesium sulfate
At delivery: 
1. C/s if malpresenting
2. delayed cord clamping 
For baby
1. avoid hypothermia
2. permissive hypercapnia 45-55
3. Treat babies with abx if mom’s have chorio or PPROM
4. Avoid inotropes unless markers of hypoperfusion
5. head position neutral and midline
6. Prophylactic indomethacin for high risk, extreme prems
65
Q

Leukoreduction of RBCs decrease

A

CMV

66
Q

Irradiation of RBCs reduce

A

Risk of GVHD

67
Q

Pretransfusion testing for neonates

A
  • ABO grouping and RH typing
  • Screen for maternal antibodies (direct and indirect antiglobulin test)
    If initial screen is negative do NOT repeat the screen again until 4 months of age
68
Q

Indications for treatment for ROP

A

Zone I – any stage with plus disease
Zone I – stage 3 without plus disease
Zone II – stage 2 or 3 ROP with plus disease

69
Q

Who to screen for ROP

A
  • Born <= 30+ 6 OR
  • BWt < = 1250 OR
  • More mature infants believed to be at high risk
70
Q

When to screen for ROP

A

At 4 weeks of age OR 31 weeks CGA which ever comes later

71
Q

Surfactant replacement therapy benefits:

A

Reduces:

  • mortality
  • deficits in oxygenation
  • pulmonary air leaks
  • duration of ventilatory support
  • length hospital stay
  • cost of intensive care

Increases:
- likelihood of surviving without BPD

72
Q

Risks of endogenous surfactant use

A
  • During instillation: bradycardia, hypoxemia, blockage of endotracheal tube
  • Pulmonary hemorrhage
  • Overdistention
  • Hyperventilation with low PCO2
73
Q

Surfactant is indicated for:

6

A
  • Intubated infants with RDS
  • Infants at significant risk of RDS
  • Re-treatment for RDS if O2 requirement of 30% or more
  • Intubated infants with MAS requiring more than 50% oxygen
  • Sick newborns with pneumonia and OI > 15
  • Newborns with pulmonary hemorrhage which leads to clinical deterioration
74
Q

Complications of depression on pregnancy and infancy

A

Pregnancy: suicide, miscarriage, preterm birth, low birth weight, resp distress, increased length of hospital stay
Infancy: maternal child bonding, cognitive, emotional and behavioural consequences

75
Q

SSRI exposure and congenital malformations

A
  • SSRIs unlikely to be associated

- Paroxetine may be associated with cardiac malformations (inconclusive)

76
Q

SSRI impacts on newborn

A
  • SSRI neonatal behavioural syndrome in 10-30% (mild and self limited, observe for 48hrs)
  • Possible PPHN (absolute risk = negligible)
  • Possible: lower BWt, lower GA, resp distress, admission to NICU
77
Q

Responsibilities of referral team in critical transport

A
  • Copies of medical records
  • Maternal blood sample and colostrum
  • Placenta for pathology
  • Consent for transport
  • Consent specific for blood product administration
78
Q

Recommendations for steroids in extreme prems

A

May be recommended:

  • High risk infants (<28 weeks) and those exposed to chorio MAY benefit from physiologic hydrocortisone at replacement doses (e.g. within first 24-48 hrs)
  • For subgroup of infants (e.g. ventilated with increasing O2 and worsening lung disease) a short course of dex should be considered AFTER 1 week

Is NOT/cannot be recommended:

  • use of dex in first week post birth
  • Routine use of dex for infants after first weeks is NOT recommended (nor HC)
  • routine use ICS
79
Q

3 types of vitamin K deficiency bleeding

A
  1. Early onset = first 24hrs post birth (e.g. maternal antiepileptics)
  2. Classic = days 2-7
  3. Late onset (2-12 weeks up to 6 months) – associated with chronic malabsorption and low vit K intake
80
Q

Oral vitamin K option

A

2mg at first feeding then repeated at 2-4 weeks and then 6-8 weeks

Studying (25 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions